Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KOSDAQ - Delayed Quote KRW

TELCON RF PHARMACEUTICAL. Inc. (200230.KQ)

Compare
3,030.00
-10.00
(-0.33%)
At close: April 4 at 3:30:20 PM GMT+9
Currency in KRW All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
37,865,282.08
37,865,282.08
36,307,203.78
27,829,999.16
37,841,150.31
Cost of Revenue
27,556,305.61
27,556,305.61
26,719,876.96
22,165,536.13
28,716,000.10
Gross Profit
10,308,976.47
10,308,976.47
9,587,326.82
5,664,463.03
9,125,150.21
Operating Expense
10,379,525
10,379,525
8,622,011
9,727,457
11,866,471
Operating Income
-70,548.53
-70,548.53
965,315.82
-4,062,993.97
-2,741,320.79
Net Non Operating Interest Income Expense
-3,662,246.39
-3,662,246.39
-170,054.95
-1,008,013.14
-7,656,497.25
Pretax Income
-26,499,982.35
-26,499,982.35
13,948,744.64
-42,117,159.48
-22,875,430.49
Net Income Common Stockholders
-26,319,870.06
-26,319,870.06
13,906,405.51
-42,084,350.43
-23,098,051.47
Basic EPS
-2.23k
--
12.44k
-3.97k
-2.63k
Diluted EPS
-2.23k
--
10.25k
-3.97k
-2.63k
Basic Average Shares
11,829.16
--
11,214.84
10,600.59
8,782.53
Diluted Average Shares
11,829.16
--
--
10,600.59
8,782.53
Total Operating Income as Reported
-70,548.30
-70,548.30
965,315.60
-4,062,993.47
-2,741,321.05
Rent Expense Supplemental
14,282
14,282
15,296
21,129
34,917
Total Expenses
37,935,830.61
37,935,830.61
35,341,887.96
31,892,993.13
40,582,471.10
Net Income from Continuing & Discontinued Operation
-26,319,870.06
-26,319,870.06
13,906,405.51
-42,084,350.43
-23,098,051.47
Normalized Income
-29,405,568.06
-29,405,568.06
4,424,080.07
-23,460,194.43
-22,576,436.99
Interest Income
324,967
324,967
188,894
54,726
45,482
Interest Expense
3,759,900
3,759,900
603,578
1,062,740
7,701,980
Net Interest Income
-3,662,246.39
-3,662,246.39
-170,054.95
-1,008,013.14
-7,656,497.25
EBIT
-22,740,082.35
-22,740,082.35
14,552,322.64
-41,054,419.48
-15,173,450.49
EBITDA
-18,233,365.35
-18,233,365.35
18,796,559.64
-36,772,955.48
-10,973,469.49
Reconciled Cost of Revenue
27,556,305.61
27,556,305.61
26,719,876.96
22,165,536.13
28,716,000.10
Reconciled Depreciation
4,506,717
4,506,717
4,244,237
4,281,464
4,199,981
Net Income from Continuing Operation Net Minority Interest
-26,319,870.06
-26,319,870.06
13,906,405.51
-42,084,350.43
-22,766,633.99
Total Unusual Items Excluding Goodwill
3,085,698
3,085,698
12,476,744
-18,624,156
-190,197
Total Unusual Items
3,085,698
3,085,698
12,476,744
-18,624,156
-190,197
Normalized EBITDA
-21,319,063.35
-21,319,063.35
6,319,815.64
-18,148,799.48
-10,783,272.49
Tax Rate for Calcs
--
--
0
--
--
Tax Effect of Unusual Items
--
--
2,994,418.56
--
--
12/31/2021 - 11/24/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers